Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1

被引:9
|
作者
Wang, Tiantian [1 ,2 ]
Pang, Lidan [1 ]
He, Mengni [1 ]
Wang, Zengtao [1 ]
机构
[1] Jiangxi Univ Chinese Med, Coll Pharm, Nanchang 330004, Peoples R China
[2] Jiangxi Univ Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese He, Nanchang 330006, Peoples R China
关键词
ASK1; inhibitors; Reviews; Optimization strategies; Structure-activity relationships; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; NEURONAL CELL-DEATH; ASK1; INHIBITOR; INCREASED VULNERABILITY; DEPENDENT ACTIVATION; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS;
D O I
10.1016/j.ejmech.2023.115889
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Apoptosis signal regulated kinase 1 (ASK1, also known as MAP3K5) is a member of the mitogen activated protein kinase kinase kinase (MAP3K) family. Since its first isolation from a human macrophage library in 1996, its research has been ongoing for over 25 years. A large number of reports have revealed that ASK1, as a key activator of the p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK) signaling cascade, responds to various stressors, and its inhibitors have important potential value in the treatment of diseases such as inflammation, cancer, and the nervous system and so on. This review summarizes the recent development in this field, including the structure and signaling pathways of ASK1, with a particular focus on the structureactivity relationships, and the hit-to-lead optimization strategies.
引用
收藏
页数:31
相关论文
共 50 条
  • [1] Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors
    Fu, Leilei
    Chen, Siwei
    He, Gu
    Chen, Yi
    Liu, Bo
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (20) : 13561 - 13573
  • [2] Small-molecule inhibitors for targeting polo-like kinase 1
    Kolosenko, Iryna
    Palm-Apergi, Caroline
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (16) : 1457 - 1460
  • [3] Development of Extracellular Signal-Regulated Kinase Inhibitors
    Burkhard, Kimberly
    Smith, Sarice
    Deshmukh, Rahul
    MacKerell, Alexander D., Jr.
    Shapiro, Paul
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 678 - 689
  • [4] Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules
    Goebel, Georg L.
    Qiu, Xiaqiu
    Wu, Peng
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (10) : 866 - 881
  • [5] Allosteric small-molecule kinase inhibitors
    Wu, Peng
    Clausen, Mads H.
    Nielsen, Thomas E.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 59 - 68
  • [6] The role and regulation of apoptosis signal-regulated kinase 1 in liver disease
    Yining Lu
    Yanning Liu
    Min Zheng
    Molecular Biology Reports, 2022, 49 : 10905 - 10914
  • [7] The role and regulation of apoptosis signal-regulated kinase 1 in liver disease
    Lu, Yining
    Liu, Yanning
    Zheng, Min
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (11) : 10905 - 10914
  • [8] Induction of apoptosis by novel substrate selective extracellular signal-regulated kinase (ERK) inhibitors
    Smith, Sarice R.
    Shapiro, Paul
    FASEB JOURNAL, 2008, 22
  • [9] The development of small-molecule inhibitors targeting HPK1
    Zhou, Lixin
    Wang, Tianyu
    Zhang, Kuojun
    Zhang, Xiangyu
    Jiang, Sheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [10] Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors
    Jiang, Jie
    Gui, Fu
    He, Zhixiang
    Li, Li
    Li, Yunzhan
    Li, Shunying
    Wu, Xinrui
    Deng, Zhou
    Sun, Xihuan
    Huang, Xiaoxing
    Huang, Wei
    Han, Shang
    Zhang, Ting
    Wang, Zheng
    Jiao, Bo
    Song, Siyang
    Wang, Hongrui
    Chen, Lanfen
    Zhou, Dawang
    Liu, Qiang
    Ren, Ruibao
    Zhang, Jianming
    Deng, Xianming
    CANCER RESEARCH, 2017, 77 (01) : 175 - 186